All Stories

  1. An overview of ceftolozane sulfate + tazobactam for treating hospital acquired pneumonia
  2. Riesgo de infección asociado a nuevas terapias para el tratamiento de los síndromes linfoproliferativos
  3. Effects of the extracorporeal membrane oxygenation circuit on plasma levels of ceftolozane
  4. Phaeohyphomycosis caused by Medicopsis romeroi in solid organ transplant recipients: Report of two cases and comprehensive review of the literature
  5. Infections by OXA-48-like-producing Klebsiella pneumoniae non-co-producing extended spectrum beta-lactamase: can they be treated successfully with cephalosporins?
  6. Prognostic factors in 264 adults with invasive Scedosporium spp. and Lomentospora prolificans infection reported in the literature and FungiScope®
  7. Is antibody-mediated rejection in kidney transplant recipients a risk factor for developing cytomegalovirus or BK virus infection? Results from a case-control study
  8. Lung transplantation in two cystic fibrosis patients infected with previously pandrug-resistant Burkholderia cepacia complex treated with ceftazidime–avibactam
  9. Community-acquired respiratory viruses are a risk factor for chronic lung allograft dysfunction
  10. Clinical Characteristics and Outcome of Lung Transplant Recipients with Respiratory Isolation ofCorynebacteriumspp.
  11. Ceftolozane/tazobactam for the treatment of XDR Pseudomonas aeruginosa infections
  12. Prevalence of Chagas Disease among Solid Organ–Transplanted Patients in a Nonendemic Country
  13. Case Report: Successful Lung Transplantation from a Donor Seropositive for Trypanosoma cruzi Infection (Chagas Disease) to a Seronegative Recipient
  14. Successful liver transplantation despite donor-transmitted ESBL-producing Klebsiella pneumoniae infection: Case report and review of the literature
  15. Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)
  16. Executive summary of the diagnosis and treatment of urinary tract infection: Guidelines of the Spanish Society of Clinical Microbiology and Infectious Diseases (SEIMC)
  17. Reply to “Activity of Fosfomycin on Clinical Isolates of Campylobacter jejuni and Campylobacter coli of Enteric Origin”
  18. Determination of neutrophil CD64 expression as a prognostic biomarker in patients with community-acquired pneumonia
  19. Fosfomycin for Recurrent Campylobacter
  20. Long-Term Fosfomycin-Tromethamine Oral Therapy for Difficult-To-Treat Chronic Bacterial Prostatitis
  21. Epidemiology and Diagnosis of Tuberculous Lymphadenitis
  22. Reply
  23. A 72-Year-Old Man With Dyspnea, Circumferential Aortic Thickening, and Weight Loss